Heart Disease Clinical Trials in District of Columbia

179 recruiting studies across 1 city

Browse by City

All Trials in District of Columbia

Phase

Trial	Phase	Sponsor	Dist.
Product Surveillance Registry	—	Medtronic	<1 mi
Coronary Microvascular Disease (CMD) Registry	—	Medstar Health Research Institute	<1 mi
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products	—	Medtronic	<1 mi
Optimal Pacing Rate for Cardiac Resynchronization Therapy	N/A	Medstar Health Research Institute	<1 mi
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.	N/A	Medtronic Cardiovascular	<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	<1 mi
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG	Phase 3	Icahn School of Medicine at Mount Sinai	<1 mi
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery	Phase 3	Yale University	<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease	—	Children's Hospital Medical Center, Cincinnati	<1 mi
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE	—	Medtronic Cardiovascular	<1 mi
Pediatric Adhesion and New Dermal Approach Study	N/A	iRhythm Technologies, Inc.	<1 mi
J-Valve Transfemoral Pivotal Study	N/A	JC Medical, Inc., an affiliate of Edwards Lifesciences LLC	<1 mi
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS	Phase 3	DalCor Pharmaceuticals	<1 mi
MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients	—	Children's National Research Institute	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
Vosoritide for Short Stature in Turner Syndrome	Phase 2	Roopa Kanakatti Shankar, MBBS, MS	<1 mi
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)	—	Bristol-Myers Squibb	<1 mi
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair	N/A	NeoChord	<1 mi
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)	Phase 3	NYU Langone Health	<1 mi
Prevent Cardiac Surgery Associated AKI Trial	Phase 2	George Washington University	<1 mi
SELUTION 4 De Novo Small Vessel IDE Trial	N/A	M.A. Med Alliance S.A.	<1 mi
Abatacept in Immune Checkpoint Inhibitor Myocarditis	Phase 3	Massachusetts General Hospital	<1 mi
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients	Phase 4	University of Rochester	<1 mi
Cooperative Assessment of Late Effects for SCD Curative Therapies	—	Vanderbilt University Medical Center	<1 mi
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).	N/A	Mayra Guerrero	<1 mi
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.	Phase 4	Pfizer	<1 mi
Technical Development of Cardiovascular Magnetic Resonance Imaging	—	National Heart, Lung, and Blood Institute (NHLBI)	<1 mi
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II	N/A	Shockwave Medical, Inc.	<1 mi
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia	Phase 3	Novartis Pharmaceuticals	<1 mi
Prevail Global Study	N/A	Medtronic Vascular	<1 mi
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy	Phase 3	Alnylam Pharmaceuticals	<1 mi
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	Phase 3	Johns Hopkins University	<1 mi
Hydrogen's Feasibility and Safety as a Therapy in ECPR	Phase 1	Boston Children's Hospital	<1 mi
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)	—	The Society of Thoracic Surgeons	<1 mi
STOP AF First Post-Approval Study	—	Medtronic Cardiac Ablation Solutions	<1 mi
Omega-3D: Omega-3 for Diet-Driven Health Disparities	Phase 2	University of Arizona	<1 mi
Implantable Cardioverter Defibrillator (ICD Registry)	—	American College of Cardiology	<1 mi
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)	Phase 2/3	Merck Sharp & Dohme LLC	<1 mi
Pediatric Prehospital Airway Resuscitation Trial	N/A	Ohio State University	<1 mi
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Phase 3	Mezzion Pharma Co. Ltd	<1 mi
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior	Phase 2/3	University of Utah	<1 mi
Left Atrial Appendage Occlusion Registry (LAAO Registry)	—	American College of Cardiology	<1 mi
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy	Phase 2	Imbria Pharmaceuticals, Inc.	<1 mi
TECTONIC CAD IVL IDE Study	N/A	Abbott Medical Devices	<1 mi
STS/ACC TVT Registry Mitral Module	—	American College of Cardiology	<1 mi
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates	N/A	University of British Columbia	<1 mi
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure	N/A	Abbott Medical Devices	<1 mi
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention	—	Johns Hopkins University	<1 mi
Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	<1 mi
ASCEND CSP IDE Study	N/A	Abbott Medical Devices	<1 mi
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures	—	Boston Children's Hospital	<1 mi
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry	—	University of Colorado, Denver	<1 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR	N/A	Cardiac Dimensions, Inc.	<1 mi
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study	N/A	Ancora Heart, Inc.	<1 mi
The JenaValve ALIGN-AR LVAD Registry	N/A	JenaValve Technology, Inc.	<1 mi
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment	Phase 2	BioMarin Pharmaceutical	<1 mi
The CONFORM Pivotal Trial	N/A	Conformal Medical, Inc	<1 mi
FORWARD CAD IDE Study	N/A	Shockwave Medical, Inc.	<1 mi
Tracking Results of Ablations to Combat AF Registry Generation 2	—	AtriCure, Inc.	<1 mi
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block	—	The Hospital for Sick Children	<1 mi
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia	Phase 3	Novartis Pharmaceuticals	<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	<1 mi
Study of JK07 in Patients With Chronic Heart Failure	Phase 2	Salubris Biotherapeutics Inc	4 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	6 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events	Phase 3	Amgen	6 mi
Defining the Brain Phenotype of Children With Williams Syndrome	—	National Institute of Mental Health (NIMH)	6 mi
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax	—	National Heart, Lung, and Blood Institute (NHLBI)	6 mi
Evaluating New Radiation Techniques for Cardiovascular Imaging	N/A	National Heart, Lung, and Blood Institute (NHLBI)	6 mi
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention	—	National Heart, Lung, and Blood Institute (NHLBI)	6 mi
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank	—	National Heart, Lung, and Blood Institute (NHLBI)	6 mi
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial	N/A	National Cancer Institute (NCI)	6 mi
Diabetes and Heart Disease Risk in Blacks	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	6 mi
New Heart Imaging Techniques to Evaluate Possible Heart Disease	N/A	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	6 mi
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies	—	National Cancer Institute (NCI)	6 mi
Nightmare Deconstruction and Reprocessing vs. NightWare Wristband	Phase 2	Uniformed Services University of the Health Sciences	6 mi
Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging	—	National Heart, Lung, and Blood Institute (NHLBI)	6 mi
Dietary Behavior Intervention in African Americans at Risk for Cardiovascular Disease	N/A	National Institutes of Health Clinical Center (CC)	6 mi
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System	—	National Heart, Lung, and Blood Institute (NHLBI)	6 mi
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy	—	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	6 mi
Natural History of Noncirrhotic Portal Hypertension	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	6 mi
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	6 mi
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis	Phase 2	Novartis Pharmaceuticals	7 mi
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation	Phase 3	Novo Nordisk A/S	7 mi
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart	Phase 3	Boehringer Ingelheim	7 mi
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)	Phase 3	Anthos Therapeutics, Inc.	7 mi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin	Phase 3	AstraZeneca	7 mi
Early Screening and Treatment of Heart Complication in Sickle Cell Disease	Phase 2	Inova Health Care Services	7 mi
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)	Phase 2	Merck Sharp & Dohme LLC	7 mi
Left vs Left Randomized Clinical Trial	N/A	Baylor College of Medicine	7 mi
Medtronic Cardiac Surgery PMCF Registry	—	Medtronic Cardiac Surgery	7 mi
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm	—	Inova Health Care Services	7 mi
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance	—	Minneapolis Heart Institute Foundation	7 mi
ELEVATE-HFpEF Clinical Study	N/A	Medtronic Cardiac Rhythm and Heart Failure	7 mi
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)	N/A	Biosense Webster, Inc.	7 mi
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function	Phase 3	AstraZeneca	7 mi
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)	Phase 2	Bristol-Myers Squibb	7 mi
Inova Cardiogenic Shock Registry (INOVA SHOCK)	—	Inova Health Care Services	7 mi
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock	—	STAVROS G DRAKOS	7 mi
Cardiogenic Shock Working Group Registry	—	Tufts Medical Center	7 mi
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs	—	Inova Health Care Services	7 mi
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial	N/A	Inova Health Care Services	7 mi
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova	N/A	Inova Health Care Services	7 mi
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels	—	Inova Health Care Services	7 mi
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy	Phase 2	Novo Nordisk A/S	7 mi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure	N/A	BrioHealth Solutions, Inc.	7 mi
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation	N/A	Boston Scientific Corporation	7 mi
CTSN Embolic Protection Trial	N/A	Icahn School of Medicine at Mount Sinai	7 mi
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation	Phase 3	Novo Nordisk A/S	8 mi
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR	N/A	Edwards Lifesciences	8 mi
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation	—	Heart Rhythm Clinical and Research Solutions, LLC	10 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity	Phase 3	Amgen	11 mi
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension	Phase 2	Retension Pharmaceuticals. Inc.	12 mi
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF	Phase 2	Cytokinetics	12 mi
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation	Phase 2	Regeneron Pharmaceuticals	14 mi
PARTNER 3 Trial - Aortic Valve-in-Valve	N/A	Edwards Lifesciences	15 mi
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Phase 4	Dennis M. McNamara, MD, MS	15 mi
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry	—	SCAD Alliance	15 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	15 mi
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions	Phase 4	Yale University	15 mi
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD	N/A	Cleerly, Inc.	17 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	17 mi
Inherited Retinal Degenerative Disease Registry	—	Foundation Fighting Blindness	25 mi
CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation	Phase 3	Cardiol Therapeutics Inc.	25 mi
AltaValve Pivotal Trial	N/A	4C Medical Technologies, Inc.	25 mi
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM	—	Lexeo Therapeutics	25 mi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure	Phase 3	Boehringer Ingelheim	26 mi
Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction	N/A	Medstar Health Baltimore	35 mi
Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)	N/A	Johns Hopkins University	35 mi
Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure	N/A	University of Michigan	35 mi
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III	N/A	Endotronix, Inc.	35 mi
320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.	N/A	Johns Hopkins University	35 mi
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure	N/A	Johns Hopkins University	35 mi
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry	—	Leiden University Medical Center	35 mi
Heart Attack Research Program- Imaging Study	—	NYU Langone Health	35 mi
Mobile Health Technology-Enabled AFib Management	N/A	Johns Hopkins University	35 mi
CORE-COMPARE Pilot Study	N/A	Johns Hopkins University	35 mi
The ENCIRCLE Trial	N/A	Edwards Lifesciences	35 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	35 mi
Rilonacept in Subjects With Cardiac Sarcoidosis	Phase 2	Mayo Clinic	35 mi
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease	N/A	Population Health Research Institute	35 mi
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial	N/A	Edwards Lifesciences	35 mi
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure	—	Johns Hopkins University	35 mi
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy	Phase 3	Lexicon Pharmaceuticals	35 mi
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves	N/A	Edwards Lifesciences	35 mi
Focused Orticumab Research for Treating Inflammation in Coronary Arteries	Phase 2	Abcentra	35 mi
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction	—	Northwestern University	35 mi
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)	Phase 2	Pfizer	35 mi
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women	N/A	Weill Medical College of Cornell University	35 mi
Left Ventricular Structural Predictors of Sudden Cardiac Death	—	Johns Hopkins University	35 mi
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation	N/A	University of California, San Francisco	35 mi
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)	Phase 2	Tectonic Therapeutic	35 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment	—	Children's Oncology Group	35 mi
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System	N/A	Boston Scientific Corporation	35 mi
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]	N/A	Johns Hopkins University	35 mi
Women's Heart Attack Research Program: Stress Ancillary Study	N/A	NYU Langone Health	35 mi
The Fourth Left Atrial Appendage Occlusion Study	N/A	Hamilton Health Sciences Corporation	35 mi
Community Health Worker-Led Intervention to Increase Cardiac Rehabilitation Participation	N/A	Johns Hopkins University	35 mi
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)	Phase 3	Boehringer Ingelheim	35 mi
Cord Clamping Among Neonates With Congenital Heart Disease	N/A	Carl Backes, MD	35 mi
Cardiopulmonary Bypass Induced Red Blood Cell Lysis	—	University of Maryland, Baltimore	35 mi
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections	N/A	Inflammatix	35 mi
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)	N/A	University of Michigan	35 mi
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)	N/A	Annetine Gelijns	35 mi
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study	Phase 2/3	Kardigan, Inc.	35 mi
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma	—	Children's Oncology Group	35 mi
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)	N/A	Sunnybrook Health Sciences Centre	35 mi
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC	Phase 1	Tenaya Therapeutics	35 mi
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk	—	Johns Hopkins University	35 mi
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy	N/A	University of Rochester	35 mi
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)	—	Tenaya Therapeutics	35 mi
Brain Volume and Cardiac Function in Heart Failure	N/A	Johns Hopkins University	35 mi
PRIMARY Ancillary Substudy	N/A	Annetine Gelijns	35 mi
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism	—	Johns Hopkins University	35 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction	Phase 3	Cytokinetics	35 mi
Quality of Pediatric Resuscitation in a Multicenter Collaborative	—	Children's Hospital of Philadelphia	35 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	35 mi
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome	Phase 3	Albireo, an Ipsen Company	35 mi
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)	Phase 4	University of Maryland St. Joseph Medical Center	41 mi
A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)	Phase 2	Genentech, Inc.	42 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.